ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ANIP ANI Pharmaceuticals Inc

55.44
0.16 (0.29%)
After Hours
Last Updated: 00:24:49
Delayed by 15 minutes
Share Name Share Symbol Market Type
ANI Pharmaceuticals Inc NASDAQ:ANIP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.16 0.29% 55.44 54.00 57.82 56.63 54.955 55.60 156,244 00:24:49

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

30/12/2024 9:05pm

GlobeNewswire Inc.


ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart


From Dec 2024 to Jan 2025

Click Here for more ANI Pharmaceuticals Charts.

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer; Stephen Carey, Chief Financial Officer; and Dr. Mary Pao, Chief Medical Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 2:15pm PST/5:15pm EST, in San Francisco.

The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business. For more information, visit www.anipharmaceuticals.com.

Investor Relations: Lisa M. Wilson, In-Site Communications, Inc.T: 212-452-2793 E: lwilson@insitecony.com

Source: ANI Pharmaceuticals, Inc.

1 Year ANI Pharmaceuticals Chart

1 Year ANI Pharmaceuticals Chart

1 Month ANI Pharmaceuticals Chart

1 Month ANI Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock